Company Elanix Biotechnologies AG Xetra
Equities
ELN
DE000A0WMJQ4
Biotechnology & Medical Research
Business Summary
Number of employees: 11
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 11-12-31 | |
Egon Minar
DFI | Director of Finance/CFO | - | 18-05-28 |
Chief Tech/Sci/R&D Officer | - | - | |
Public Communications Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Marco Christen
CHM | Chairman | - | 20-02-26 |
Director/Board Member | - | 21-05-03 | |
Director/Board Member | - | 23-02-09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,080,902 | 3,264,982 ( 40.40 %) | 0 | 40.40 % |
Company contact information
Elanix Biotechnologies AG
Hanauer Landstrasse 291 B
60314, Frankfurt
+
http://www.elanix-biotechnologies.deSector
1st Jan change | Capi. | |
---|---|---|
+24.38% | 48.09B | |
+46.90% | 40.62B | |
-3.04% | 40.43B | |
-6.20% | 28.36B | |
+9.49% | 24.89B | |
-20.01% | 19.01B | |
+29.21% | 12.09B | |
+0.72% | 11.88B | |
-0.93% | 11.8B |